RxDoctor Payments Data

Thomas Walter, MD

Gynecology · Clearwater, FLNPI 1881681492

Payments from drug & device makers

$1,251in general payments, 2019–2025

Across 54 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • Myovant Sciences Inc.$178
  • Pfizer$163
  • Mayne Pharma Commercial LLC$160
  • Astellas Pharma US Inc$81
  • Hologic Sales And Service, LLC$50
  • plus $268 from 11 others

What the payments were for

  • Food & beverage$1,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,251 in reported general payments places this provider in the 60th percentile of 290 gynecology providers in Florida.

See all gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$30,585
Medicare patients
114
Services billed
347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated57$26,153
Estradiol181$5,152
PremproEstrogen,con/M-Progest Acet13$4,938
Estradiol (Twice Weekly)Estradiol25$2,399
ValacyclovirValacyclovir Hcl20$1,493
Estradiol (Once Weekly)Estradiol12$1,316
ProgesteroneProgesterone, Micronized25$529
Clobetasol Propionate25$446
Medroxyprogesterone Acetate14$288

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Prempro$163$31,09170 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 290 gynecology providers in Florida.

Other gynecology in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →